Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GLP-1 attenuates intestinal fat absorption and chylomicron production via vagal afferent nerves originating in the portal vein
Simon Hoffman, Danielle Alvares, Khosrow Adeli
Molecular Metabolism (2022) Vol. 65, pp. 101590-101590
Open Access | Times Cited: 19

Showing 19 citing articles:

Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism
Tong Bu, Ziyan Sun, Yi Pan, et al.
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 3, pp. 354-372
Open Access | Times Cited: 23
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
Merlin C. Thomas, Melinda T. Coughlan, Mark E. Cooper
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 253-273
Open Access | Times Cited: 33
The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist
Yun Kyung Cho, Yoo La Lee, Chang Hee Jung
Journal of Lipid and Atherosclerosis (2023) Vol. 12, Iss. 3, pp. 213-213
Open Access | Times Cited: 25
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Simon Hoffman, Khosrow Adeli
Medical Review (2024) Vol. 4, Iss. 4, pp. 301-311
Open Access | Times Cited: 9
Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice
Zhixiong Ying, Robin van Eenige, Xiaoke Ge, et al.
EBioMedicine (2023) Vol. 93, pp. 104684-104684
Open Access | Times Cited: 13
Bile acids and incretins as modulators of obesity-associated atherosclerosis
Andrijana Kirsch, Juergen Gindlhuber, Diana Zabini, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 11
Open Access
Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemia
Brian Tomlinson, Paul Chan
Expert Opinion on Pharmacotherapy (2025), pp. 1-11
Closed Access
Glucose-dependent insulinotropic polypeptide stimulates post-absorptive lipid secretion in the intestine
Rong Wang, Muhammad Asaf Khan, Kundanika Mukherjee, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access
Hyperlipidaemia treatment and gut microbiology
Zhe Liu, Yu ChunLi
Frontiers in Microbiology (2025) Vol. 15
Open Access
Tirzepatide and major adverse limb events: Insights from a multicenter real-world analysis in PAD and diabetes patients
Jheng‐Yan Wu, Wu-Hao Tu, Tsung Yu, et al.
Diabetes Research and Clinical Practice (2025) Vol. 222, pp. 112083-112083
Closed Access
ANTI-OBESITY MEDICATIONS IN ADULT AND PEDIATRIC OBESITY AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Natalie Rodríguez, Phillipp Hartmann
Pharmacological Reviews (2025), pp. 100058-100058
Open Access
Fucoxanthin improves serum lipids, liver metabolism and gut microbiota in hyperlipidemia mice
Yonghui Zhou, Jingyi Zhang, Kun Xu, et al.
Deleted Journal (2024)
Open Access | Times Cited: 3
Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an update
Brian Tomlinson, Paul Chan
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 4, pp. 175-179
Closed Access | Times Cited: 2
Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes
Clifford J. Bailey, Peter R. Flatt
Peptides (2024) Vol. 174, pp. 171168-171168
Closed Access | Times Cited: 1
Emerging therapeutic landscape: Incretin agonists in chronic kidney disease management
Kexin Lian, Kexin Zhang, Chengxia Kan, et al.
Life Sciences (2024) Vol. 351, pp. 122801-122801
Closed Access | Times Cited: 1
Baicalein Ameliorates Insulin Resistance of HFD/STZ Mice through Activating PI3K/AKT Signal Pathway of Liver and Skeletal Muscle in a GLP-1R-Dependent Manner
Na Liu, Xin Cui, Tingli Guo, et al.
Antioxidants (2024) Vol. 13, Iss. 10, pp. 1246-1246
Open Access | Times Cited: 1
Hormone based therapy and crosstalk beyond hormones
Tianru Jin
Medical Review (2024) Vol. 4, Iss. 4, pp. 257-261
Open Access
Peripheral serotonin controls dietary fat absorption and chylomicron secretion via 5-HT4 receptor in males
Fitore Raka, Simon Hoffman, Asal Nady, et al.
Endocrinology (2024) Vol. 165, Iss. 10
Open Access
BEYOND BLOOD SUGAR CONTROL: A COMPREHENSIVE REVIEW OF DPP-4 INHIBITORS AND THEIR EXPANDING LANDSCAPE
Parul Srivastava, Pranay Wal, Versha Chaturvedi, et al.
Journal of Population Therapeutics and Clinical Pharmacology (2022)
Open Access
Page 1

Scroll to top